Anti-hyperuricemic and nephroprotective effects of Smilax china L.

Journal of Ethnopharmacology

Volumn 135, Issue 2, 2011, Pages 399-405

  Chen, Lvyi ^a   Yin, Huafeng ^a   Lan, Zhou ^a   Ma, Shuwei ^a   Zhang, Chunfeng ^a   Yang, Zhonglin ^a   Li, Ping ^a   Lin, Baoqin ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Anti hyperuricemic agents; Hyperuricemia; Nephroprotection; Smilax china L.; Uric acid

Indexed keywords

ASTILBIN; CAFFEIC ACID; CHLOROGENIC ACID; ENGELETIN; OXYRESVERATROL; PLANT EXTRACT; POLYDATIN; PROTOCATECHUALDEHYDE; RESVERATROL; RUTOSIDE; SMILAX CHINA EXTRACT; UNCLASSIFIED DRUG; URATE; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; ENZYME INHIBITION; HYPERURICEMIA; IC 50; KIDNEY DYSFUNCTION; MALE; MOUSE; NONHUMAN; RAT; RENAL PROTECTION; SARSAPARILLA; SMILAX CHINA; UREA NITROGEN BLOOD LEVEL;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME INHIBITORS; HYPERURICEMIA; KIDNEY; MALE; MICE; MICE, INBRED ICR; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SMILAX; XANTHINE OXIDASE;

ANIMALIA; MUS; RATTUS; SMILAX CHINA;

EID: 79955697792     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2011.03.033     Document Type: Article

References (36)

1. N. Anzai, A. Enomoto, and H. Endou Renal urate handling: clinical relevance of recent advances Current Rheumatology Reports 7 2005 227 234
2. O.M. Arafat, S.Y. Tham, A. Sadikun, I. Zhari, P.J. Haughton, and M.Z. Asmawi Studies on diuretic and hypouricemic effects of Orthosiphon stamineus methanol extracts in rats Journal of Ethnopharmacology 118 2008 354 360
3. M.J. Caulfield, P.B. Munroe, D. O'Neill, K. Witkowska, F.J. Charchar, M. Doblado, S. Evans, S. Eyheramendy, A. Onipinla, P. Howard, S. Shaw-Hawkins, R.J. Dobson, C. Wallace, S.J. Newhouse, M. Brown, J.M. Connell, A. Dominiczak, M. Farrall, G.M. Lathrop, N.J. Samani, M. Kumari, M. Marmot, E. Brunner, J. Chambers, P. Elliott, J. Kooner, M. Laan, E. Org, G. Veldre, M. Viigimaa, F.P. Cappuccio, C. Ji, R. Iacone, P. Strazzullo, K.H. Moley, and C. Cheeseman SLC2A9 is a high-capacity urate transporter in humans PLoS Medicine 5 2008 197
4. W.S. Chan, P.C. Wen, and H.C. Chiang Structure-activity relationship of caffeic acid analogues on xanthine oxidase inhibition Anticancer Research 15 1995 703 707
5. Y. Chen, Q. Wang, B. Li, L. Li, L.N. Pan, and Y. Huang Study on identification and quality for Smilax China L. of compound Gout granules Asia-Pacific Traditional Medicine 4 2008 237 239
6. P. Cirillo, W. Sato, S. Reungjui, M. Heinig, M. Gersch, Y. Sautin, T. Nakagawa, and R.J. Johnson Uric acid, the metabolic syndrome, and renal disease Journal of the American Society of Nephrology 17 2006 165 168
7. P Cos, L. Ying, M. Calomme, J.P. Hu, K. Cimanga, B. Van Poel, L. Pieters, A.J. Vlietinck, and D. Vanden Berghe Structure-activity relationship and classification of flavanoids as inhibitors of xanthine oxidase and superoxide scavangers Journal of Natural Products 61 1998 71 76 (Pubitemid 28086977)
8. M. Fields, C.G. Lewis, and M.D. Lure Allopurinol, an inhibitor of xanthine oxidase, reduces uric acid levels and modifies the signs associated with copper deficiency in rats fed fructose Free Radical Biology & Medicine 20 1996 595 600 (Pubitemid 26097277)
9. B. Hammer, A. Link, A. Wagner, and M. Bohm Fatal allopurinol-induced hypersensitivity in asymptomatic hyperuricemia syndrome Deutsche Medizinische Wochenschrift 126 2001 1331 1334 (Pubitemid 33116425)
10. H. Horiuchi, M. Ota, S. Nishimura, H. Kaneko, Y. Kasahara, T. Ohta, and K. Komoriya Allopurinol induces renal toxicity by impairing pyrimidine metabolism in mice Life Science 66 2000 2051 2070 (Pubitemid 30217798)
11. Q.H. Hu, C. Wang, J.M. Li, D.M. Zhang, and L.D. Kong Allopurinol, rutin, and quercetin attenuate hyperuricemia and renal dysfunction in rats induced by fructose intake: renal organic ion transporter involvement American Journal of Physiology: Renal Physiology 297 2009 1080 1091
12. K. Iseki, S. Oshiro, M. Tozawa, C. Iseki, Y. Ikemiya, and S. Takishita Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects Hypertension Research 24 2001 691 697 (Pubitemid 33133783)
13. K. Iseki, Y. Ikemiya, T. Inoue, C. Iseki, K. Kinjo, and S. Takishita Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort American Journal of Kidney Diseases 44 2004 642 650 (Pubitemid 39237608)
14. N. Ishizaka, Y. Ishizaka, E. Toda, R. Nagai, and M. Yamakado Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals Arteriosclerosis, Thrombosis, and Vascular Biology 25 2005 1038 1044 (Pubitemid 40627852)
15. L.D. Kong, J. Zhou, Y.L. Wen, J.M. Li, and C.H.K. Cheng Aesculin possesses potenthy pouricemicaction in rodents but is devoid of xanthine oxidase dehydrogenase inhibitory activity Planta Medica 68 2002 175 178 (Pubitemid 34169417)
16. R. Miatello, M. Vázquez, N. Renna, M. Cruzado, A.P. Zumino, and N. Risler Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats American Journal of Hypertension 18 2005 864 870 (Pubitemid 40745275)
17. T. Nakagawa, K.R. Tuttle, R.A. Short, and R.J. Johnson Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome Nature Clinical Practice Nephrology 1 2005 80 86
18. T. Nakagawa, H. Hu, S. Zharikov, K.R. Tuttle, R.A. Short, O. Glushakova, X. Ouyang, D.I. Feig, E.R. Block, J. Herrera-Acosta, J.M. Patel, and R.J. Johnson A causal role for uric acid in fructose-induced metabolic syndrome. American Journal of Physiology: Renal Physiology 290 2006 F 625 F 631
19. F. Perez-Ruiz, M. Calabozo, G.G. Erauskin, A. Ruibal, and A.M. Herrero-Beites Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output Arthritis & Rheumatism 47 2002 610 613 (Pubitemid 35461313)
20. H.L. Ruan, Y.H. Zhang, W. Zhao, Y.F. Tan, Z.L. Sun, and J.Z. Wu Studies on the chemical constituents of Smilax china L. Natural Product Research and Development 14 2002 35 36
21. J.L. Ruan, J.H. Zou, and Y.L. Cai Studies on chemical constituents of Smilax china Journal of Chinese Medicinal Materials 28 2005 24 26
22. N. Schlesinger Management of acute and chronic gouty arthritis: present state-of-the-art Drugs 64 2004 2399 2416 (Pubitemid 39480701)
23. X.S. Shu, Z.H. Gao, and X.L. Yang Anti-inflammatory and anti-nociceptive activities of Smilax china L. aqueous extract Journal of Ethnopharmacology 103 2006 327 332
24. B. Stavric, S. Clayman, R.E. Gradd, and D. Hebert Some in vivo effects in the rat induced by chlorprothixene and potassium oxonate Pharmacology Research Communication 7 1975 117 124
25. State Administration of Traditional Chinese Medicine of People's Republic of China (Ed.), 1999. Zhong-hua-ben-cao. Shanghai Science and Technology Publisher, Shanghai, China, pp. 157-160.
26. State Pharmacopoeia Commission of People's Republic of China (Ed.), 2010. Pharmacopoeia of People's Republic of China. China Medical Science and Technology Publishing House, Beijing, China, p. 290.
27. R.A. Terkeltaub Clinical practice. Gout The New England Journal of Medicine 349 2003 1647 1655
28. D.E. Weiner, H. Tighiouart, E.F. Elsayed, J.L. Griffith, D.N. Salem, and A.S. Levey Uric acid and incident kidney disease in the community Journal of the American Society of Nephrology 19 2008 1204 1211
29. R.L. Wortmann Gout and hyperuricemia Current Opinion in Rheumatology 14 2002 281 286 (Pubitemid 34439094)
30. L.S. Wu, X.J. Wang, H. Wang, H.W. Yang, A.Q. Jia, and Q. Ding Cytotoxic polyphenols against breast tumor cell in Smilax china L. Journal of Ethnopharmacology 130 2010 460 464
31. Y. Xu, J.Y. Liang, and Z.M. Zou Studies on chemical constituents of rhizomes of Smilax china L. China Journal of Chinese Materia Medica 21 2008 119 121
32. T.W. Yoo, K.C. Sung, H.S. Shin, B.J. Kim, B.S. Kim, J.H. Kang, M.H. Lee, J.R. Park, H. Kim, E.J. Rhee, W.Y. Lee, S.W. Kim, S.H. Ryu, and D.G. Keum Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome Circulation Journal 69 2005 928 933 (Pubitemid 41124260)
33. Z.F. Yu, W.P. Fong, Cheng, and H.K. Christopher The dual actions of morin (3,5,7,2′,4′-Pentahydroxyflavone) as a hypouricemic agent: uricosuric effect and xanthine oxidase inhibitory activity Journal of Pharmacology and Experimental Therapeutics 316 2006 169 175 (Pubitemid 43000578)
34. C.X. Zhou, J. Tanaka, C.H. Cheng, T. Higa, and R.X. Tan Steroidal alkaloids and stilbenoids from Veratrum taliense Planta Medica 65 1999 480 482 (Pubitemid 29299852)
35. X. Zhou, L. Matavelli, and E.D. Frohlich Uric acid: its relationship to renal hemodynamics and the renal renin-angiotensin system Current Hypertension Reports 8 2006 120 124 (Pubitemid 43796688)
36. J.X. Zhu, Y. Wang, L.D. Kong, C. Yang, X. Zhang, X.Z. Ji, W. Ying, D.K. Ling, Y. Cheng, and Z. Xin Effects of Biota orientalis extract and its flavonoid constituents, quercetin and rutin on serum uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver Journal of Ethnopharmacology 93 2004 133 140 (Pubitemid 38739283)